Pharmaceutical intermediates

Tirofiban hydrochloride Intermediates

3 pharmaceutical intermediates for Tirofiban hydrochloride. Indication: Unstable Angina Pectoris; Myocardial Infarction (MI); Coronary Artery Thrombosis; Acute Coronary Syndrome (ACS); Thrombosis.

提交项目 All intermediates

About Tirofiban hydrochloride

Originator: MSD
Indication: Unstable Angina Pectoris; Myocardial Infarction (MI); Coronary Artery Thrombosis; Acute Coronary Syndrome (ACS); Thrombosis
Approved Date: 05/14/1998

Available intermediates

3 intermediates currently listed for Tirofiban hydrochloride. Request specifications, documentation or a quotation for any item below.

Tirofiban hydrochloride intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
Tirofiban hydrochloride monohydrate	150915-40-5	/	/
4-(4-chlorobutyl)pyridine hydrochloride	149463-65-0	/	/
L-N-Butylsulfonyl-P-Hydroxyphenylalanine	149490-60-8	/	/

Other programs under T

Tazemetostat Hydrobromide Tazobactam Sodium Tegoprazan Tenapanor Hydrochloride Teneligliptin Tetrabenazine Tezacaftor Tianeptine sodium salt

Building toward Tirofiban hydrochloride?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →